Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Information (Tables)

v3.25.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Information  
Schedule of segment's financial information

 

 

Years Ended

December 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

 

 

 

 

Clinical

 

 

5,796,196

 

 

 

869,379

 

Nonclinical

 

 

515,934

 

 

 

1,387,359

 

Personnel related

 

 

1,891,561

 

 

 

1,813,028

 

Total research and development

 

$ 8,203,691

 

 

$ 4,069,766

 

General and administrative

 

 

4,309,551

 

 

 

3,972,140

 

Interest income

 

 

225,781

 

 

 

247,216

 

Net loss

 

$ (12,287,461 )

 

 

(7,794,690 )